Timothy Morris
InvestorVenture Partner at LongeVC
Find your path to Timothy
41 people in our graph share verified history with Timothy — schools, employers, funds. One of them is your warm intro.
About
Timothy Morris has held CFO and COO positions at pharmaceutical and biotech companies including Humanigen, Iovance Biotherapeutics (where he supported the approval of AMTAGVI, a cell therapy for solid tumors), AcelRx, VIVUS, and Questcor Pharmaceuticals. Across eight companies he has raised over $2.7 billion in equity and convertible securities, including two IPOs, and executed more than 100 strategic transactions totaling $5.7 billion. His experience covers capital formation, commercial strategy, manufacturing, and business development, including drug approvals and launches such as QSYMIA and DSUVIA.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
Aquestive TherapeuticsDBV TechnologiesHumanetics CorporationUnivercells SA
Per the firm's website.
Colleagues at LongeVC
Frequently asked questions
- Who is Timothy Morris?
- Timothy Morris has held CFO and COO positions at pharmaceutical and biotech companies including Humanigen, Iovance Biotherapeutics (where he supported the approval of AMTAGVI, a cell therapy for solid tumors), AcelRx, VIVUS, and Questcor Pharmaceuticals. Across eight companies he has raised over $2.7 billion in equity and convertible securities, including two IPOs, and executed more than 100 strategic transactions totaling $5.7 billion. His experience covers capital formation, commercial strategy, manufacturing, and business development, including drug approvals and launches such as QSYMIA and DSUVIA.
- Where does Timothy Morris work?
- Timothy Morris is Venture Partner at LongeVC.
- What does Timothy Morris invest in?
- Timothy Morris invests in Biotech.
- What boards does Timothy Morris sit on?
- Timothy Morris holds tracked board seats at Aquestive Therapeutics, DBV Technologies, Humanetics Corporation, Univercells SA.